Gastroesophageal reflux disease and atrial fibrillation: comorbidity or overlap syndrome? View of gastroenterologist

Author:

Belousova L. N.1,Chizhova O. Yu.1,Bakulin I. G.1,Sushilova A. G.1

Affiliation:

1. Federal public budget educational institution of higher education “North-West State Medical University n. a. I. I. Mechnikov”of the Ministry of Health of the Russian Federation

Abstract

Аtrial fibrillation (AF) still occupies a special place in the structure of cardiovascular diseases, both due to its high prevalence, close association with socially significant diseases, and due to the high risks of death, stroke, and other thromboembolic complications. In turn, a patient with AF is always a comorbid patient, and among extracardiac pathology, the prevalence of diseases of the upper gastrointestinal tract, especially gastroesophageal reflux disease (GERD), pay attention. Recently more and more data have appeared that indicate the non-randomness of this combination. Many authors consider GERD as another independent risk factor for AF, while others propose to consider AF as an extra-esophageal manifestation of GERD, of course, in the absence of other cardiac risk factors. This review discusses the main pathophysiological mechanisms that determine the pathogenetic relationship of AF and GERD, known to date.

Publisher

LLC Global Media Technology

Subject

General Medicine

Reference49 articles.

1. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fi brillation developed in collaboration with EACTS: Th e Task Force for the management of atrial fi brillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur. Heart J. 2016; vol. 37 (38): 2893–2962. Available at: https://academic.oup.com/ejcts/article/50/5/e1/2444542 (Accessed 8 November 2019).

2. Чижова О. Ю., Белоусова Л. Н., Бакулин И. Г. Управление рисками желудочно-кишечных кровотечений у коморбидных больных с сердечно-сосудистыми заболеваниями //Рациональная фармакотерапия в кардиологии. – 2018. – Т. 14. – № . 4. – С. 583–590. Chizhova O. Y., Belousova L. N., Bakulin I. G. Upravlenie riskami zheludochno-kishechnyh krovotechenij u komorbidnyh bol’nyh s serdechno-sosudistymi zabolevanijami [Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases]. Rational Pharmacotherapy in Cardiology, 2018; vol. 14 (4):583–590. (In Russ.) doi: 10.20996/1819–6446–2018–14–4–583–590

3. Бакулин И. Г., Чижова О. Ю., Белоусова Л. Н., и др. Эффективность и безопасность применения новых пероральных антикоагулянтов с позиции гастроэнтеролога. Вестник Северо-Западного государственного медицинского университета им. И. И. Мечникова.2018; Т. 10 (2):12–18. Bakulin I. G., Belousova L. N., Pakhomova I. G., Chizho va O. Yu. Jeff ektivnost’ i bezopasnost’ primenenija novyh peroral’nyh antikoaguljantov s pozicii gastrojenterologa [Effi cacy and safety of new oral anticoagulants: Position of gastroenterologist]. Herald of North-Western State Medical University named aft er I. I. Mechnikov. 2018; vol. 10 (2):12–18. (In Russ.) doi: 10.17816/mechnikov201810212–18

4. Колбин А.С., Мосикян А. А., Татарский Б. А. Социально– экономическое бремя фибрилляции предсердий в России: динамика за 7 лет (2010–2017 годы). Вестник аритмологии. 2018; № . 92:42–48. Kolbin A. S., Mosikyan A. A., Tatarsky B. A. Social’no– jekonomicheskoe bremja fi brilljacii predserdij v Rossii: dinamika za 7 let (2010–2017 gody) [Socioeconomic burden of atrial fi brillations in russia: seven-year trends (2010–2017)]. Jounal of arrhythmology. 2018; 92: pp.42– 48. (In Russ.)

5. Хидирова Л. Д., Яхонтов Д. А., Зенин С. А. Особенности течения фибрилляции предсердий у пациентов с коморбидностью в зависимости от проводимой терапии. Комплексные проблемы сердечно-сосудистых заболеваний. 2019; Т. 8 (2): 21–29. L. D. Khidirova, D. A. Yakhontov, S. A. Zenin. Osobennosti techenija fi brilljacii predserdij u pacientov s komorbidnost’ju v zavisimosti ot provodimoj terapii. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2019 [Atrial fi brillation in comorbid patients depending on the treatment regiment]. Complex Issues of Cardiovascular Diseases. 2019, vol. 8, no. 2 pp 21–29. doi: 10.17802/2306–1278–2019–8–2–21–29 (In Russ.)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3